Dr. Adam R Church, D.C Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 185 Main St, East Haven, CT 06512 Phone: 203-466-1111 Fax: 203-468-9684 |
Dr. Keith A Miniaci, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 53 High St, East Haven, CT 06512 Phone: 203-469-5210 Fax: 203-468-8598 |
Dr. Christopher Mark Hume, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 185 Main St, East Haven, CT 06512 Phone: 203-466-1111 Fax: 203-468-9684 |
Dr. Mark Carrano, D.C Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 441 Foxon Rd, East Haven, CT 06513 Phone: 203-878-7800 Fax: 203-468-7883 |
Carrano Chiropractic Health Center Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 441 Foxon Rd, East Haven, CT 06513 Phone: 203-868-5129 Fax: 203-468-7883 |
Atlas Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 185 Main St, East Haven, CT 06512 Phone: 203-466-1111 Fax: 203-468-9684 |
Miniaci Chiropractic And Acupuncture Center Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 53 High St, East Haven, CT 06512 Phone: 203-469-5210 Fax: 203-468-8598 |
Dr. Ralph Christopher Manna, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 36 Main St, East Haven, CT 06512 Phone: 203-467-7783 Fax: 203-467-7783 |
Timothy J Leffert, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 943 Foxon Rd, East Haven, CT 06513 Phone: 203-466-1769 Fax: 203-467-2265 |
Dr. Dennis Joseph Nastri Sr., DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 75 High St, East Haven, CT 06512 Phone: 203-469-6296 |
News Archive
Cepheid and Instrumentation Laboratory (IL) today announced that Cepheid has received clearance from the U.S. Food & Drug Administration (FDA) to market its Xpert(R) HemosIL(R) FII & FV test.
The Wall Street Journal reports that Judge J. Harvie Wilkinson said the high court should "think twice" about overturning the law. In other health law news, the White House's under-the-radar effort to build support for the overhaul appears to be working.
DiscoveryBioMed, Inc. (DBM), a human cell-based drug discovery company, learned recently that its Cystic Fibrosis Corrector Ligand (CFCL) Drug Discovery program will be funded by the NIH. The two-year award will focus on validation and prioritization of several lead CFCL chemical classes, drugs that correct the most common cystic fibrosis (CF) disease-causing mutation.
It's a metal we worry thieves will steal from our air conditioners or power lines, but inside our bodies too much copper can result in a much larger loss.
› Verified 3 days ago